Daxor (DXR) Competitors $8.50 +0.41 (+5.07%) As of 01/17/2025 02:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DXR vs. NVRO, PDEX, TLSI, ZJYL, TELA, SRTS, ECOR, FONR, GUTS, and LNSRShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Nevro (NVRO), Pro-Dex (PDEX), TriSalus Life Sciences (TLSI), Jin Medical International (ZJYL), TELA Bio (TELA), Sensus Healthcare (SRTS), electroCore (ECOR), FONAR (FONR), Fractyl Health (GUTS), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Daxor vs. Nevro Pro-Dex TriSalus Life Sciences Jin Medical International TELA Bio Sensus Healthcare electroCore FONAR Fractyl Health LENSAR Nevro (NYSE:NVRO) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings, dividends and community ranking. Do institutionals & insiders have more ownership in NVRO or DXR? 95.5% of Nevro shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 3.2% of Nevro shares are held by insiders. Comparatively, 59.0% of Daxor shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend NVRO or DXR? Nevro presently has a consensus price target of $6.30, suggesting a potential upside of 37.83%. Daxor has a consensus price target of $24.75, suggesting a potential upside of 191.18%. Given Daxor's stronger consensus rating and higher probable upside, analysts clearly believe Daxor is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nevro 3 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.77Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, NVRO or DXR? Daxor has lower revenue, but higher earnings than Nevro. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNevro$425.17M0.40-$92.21M-$1.89-2.42DaxorN/AN/AN/AN/AN/A Which has more risk & volatility, NVRO or DXR? Nevro has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Daxor has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500. Does the MarketBeat Community believe in NVRO or DXR? Nevro received 502 more outperform votes than Daxor when rated by MarketBeat users. However, 100.00% of users gave Daxor an outperform vote while only 63.11% of users gave Nevro an outperform vote. CompanyUnderperformOutperformNevroOutperform Votes50363.11% Underperform Votes29436.89% DaxorOutperform Votes1100.00% Underperform VotesNo Votes Is NVRO or DXR more profitable? Daxor has a net margin of 0.00% compared to Nevro's net margin of -16.54%. Daxor's return on equity of 0.00% beat Nevro's return on equity.Company Net Margins Return on Equity Return on Assets Nevro-16.54% -23.52% -10.83% Daxor N/A N/A N/A Does the media refer more to NVRO or DXR? In the previous week, Nevro had 9 more articles in the media than Daxor. MarketBeat recorded 10 mentions for Nevro and 1 mentions for Daxor. Nevro's average media sentiment score of -0.06 beat Daxor's score of -1.00 indicating that Nevro is being referred to more favorably in the media. Company Overall Sentiment Nevro Neutral Daxor Negative SummaryDaxor beats Nevro on 8 of the 14 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.77M$4.57B$5.25B$8.91BDividend YieldN/A43.68%5.11%4.03%P/E RatioN/A15.7662.0813.93Price / SalesN/A59.811,215.8564.38Price / CashN/A50.1443.8235.97Price / BookN/A7.795.324.79Net IncomeN/A$13.87M$122.69M$225.00M7 Day Performance3.41%1.46%-0.17%1.52%1 Month Performance4.42%12.36%3.49%4.88%1 Year Performance-14.57%32.40%25.79%20.12% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxor3.1535 of 5 stars$8.50+5.1%$24.75+191.2%-15.3%$39.77MN/A0.0037Short Interest ↑NVRONevro2.6544 of 5 stars$4.09+24.3%$6.30+54.0%-74.8%$153.26M$419.15M-2.161,215Gap UpHigh Trading VolumePDEXPro-Dex3.5941 of 5 stars$46.74-0.5%$52.00+11.3%+111.4%$152.33M$56.80M30.35140Insider TradeShort Interest ↓News CoveragePositive NewsTLSITriSalus Life Sciences3.9276 of 5 stars$4.90-5.0%$11.79+140.5%-40.6%$149.42M$26.89M-1.97106Short Interest ↑News CoverageGap DownZJYLJin Medical InternationalN/A$0.91+12.3%N/A-99.1%$141.05M$20.13M0.00245Short Interest ↑TELATELA Bio2.7734 of 5 stars$2.78-1.1%$9.25+232.7%-61.3%$109.50M$68.65M-1.64120SRTSSensus Healthcare3.3743 of 5 stars$6.38-2.4%$12.50+95.9%+142.1%$104.56M$41.31M11.1940Short Interest ↑ECORelectroCore3.4075 of 5 stars$15.44-6.7%$25.00+61.9%+141.3%$101.21M$23.33M-8.4450Short Interest ↓Positive NewsGap DownFONRFONAR0.9029 of 5 stars$15.13-0.7%N/A-20.9%$95.74M$102.01M10.81480Short Interest ↑GUTSFractyl Health1.7668 of 5 stars$1.95+5.4%$22.00+1,028.2%N/A$93.79M$97,000.00-0.16102Short Interest ↑Positive NewsGap UpHigh Trading VolumeLNSRLENSAR0.7225 of 5 stars$8.06-2.3%$8.00-0.7%+120.7%$93.62M$48.87M-5.52110Positive News Related Companies and Tools Related Companies Nevro Alternatives Pro-Dex Alternatives TriSalus Life Sciences Alternatives Jin Medical International Alternatives TELA Bio Alternatives Sensus Healthcare Alternatives electroCore Alternatives FONAR Alternatives Fractyl Health Alternatives LENSAR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DXR) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
